POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,073 | -1.5% | 5,073 | -27.1% | 0.00% | – |
| Q2 2023 | $12,254 | +23927.5% | 6,963 | -58.5% | 0.00% | -100.0% |
| Q1 2023 | $51 | +82.1% | 16,791 | +213.8% | 0.00% | +100.0% |
| Q4 2022 | $28 | -99.9% | 5,351 | -28.2% | 0.00% | – |
| Q3 2022 | $26,000 | +30.0% | 7,456 | -6.4% | 0.00% | – |
| Q2 2022 | $20,000 | +53.8% | 7,968 | +164.7% | 0.00% | – |
| Q1 2022 | $13,000 | +18.2% | 3,010 | +90.0% | 0.00% | – |
| Q4 2021 | $11,000 | -15.4% | 1,584 | -14.6% | 0.00% | – |
| Q3 2021 | $13,000 | -48.0% | 1,854 | -25.2% | 0.00% | -100.0% |
| Q2 2021 | $25,000 | -16.7% | 2,480 | -20.0% | 0.00% | 0.0% |
| Q1 2021 | $30,000 | -41.2% | 3,100 | -32.9% | 0.00% | -50.0% |
| Q4 2020 | $51,000 | +131.8% | 4,622 | +89.0% | 0.00% | – |
| Q3 2020 | $22,000 | – | 2,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |